A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements

Purpose: Alloplastic joint replacement is the mainstay treatment for end-stage temporomandibular joint (TMJ) disease. The aim of this study is to evaluate the 2 year quality of life (QoL) outcomes for patients who have undergone alloplastic TMJ total joint replacement with either custom or stock dev...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Michael J. Carter, Owen G. Ellis, Shreya Tocaciu, Michael J. McCullough, George Dimitroulis
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	Temporomandibular joint Total joint replacement Joint prosthesis End-stage joint disease Quality of life Internal medicine RC31-1245 Surgery RD1-811
Acceso en línea:	https://doaj.org/article/d73f73585aae423093067f43cdb2cb51
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d73f73585aae423093067f43cdb2cb51
record_format	dspace
spelling	oai:doaj.org-article:d73f73585aae423093067f43cdb2cb512021-11-22T04:33:24ZA 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements2667-147610.1016/j.adoms.2021.100221https://doaj.org/article/d73f73585aae423093067f43cdb2cb512022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667147621002107https://doaj.org/toc/2667-1476Purpose: Alloplastic joint replacement is the mainstay treatment for end-stage temporomandibular joint (TMJ) disease. The aim of this study is to evaluate the 2 year quality of life (QoL) outcomes for patients who have undergone alloplastic TMJ total joint replacement with either custom or stock devices. Methods: This was a retrospective cohort study of patients who had TMJ replacement with either Biomet stock or OMX custom prostheses. All patients were recruited from the patient database of a single surgeon, at a single location. QoL was assessed using a patient completed TMJ Surgery specific QoL (TMJ-S-QoL) questionnaire. Patients answered questions pertaining to pain, diet, speech and aspects related to social and mental health. Results: A 2 year follow up was completed by 26 Biomet and 40 OMX patients. Survey results demonstrated that 84.6% (N = 22) of Biomet stock and 92.5% (N = 37) of OMX custom prosthesis patients derived significant QoL benefits from their surgery. There was no difference in QoL between the two groups (p > 0.4). Conclusion: This study shows that TMJ total joint replacements provide an improved quality of life for patients with end-stage TMJ disease regardless of whether the prosthesis is stock or individually custom made.Michael J. CarterOwen G. EllisShreya TocaciuMichael J. McCulloughGeorge DimitroulisElsevierarticleTemporomandibular jointTotal joint replacementJoint prosthesisEnd-stage joint diseaseQuality of lifeInternal medicineRC31-1245SurgeryRD1-811ENAdvances in Oral and Maxillofacial Surgery, Vol 5, Iss , Pp 100221- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	Temporomandibular joint Total joint replacement Joint prosthesis End-stage joint disease Quality of life Internal medicine RC31-1245 Surgery RD1-811
spellingShingle	Temporomandibular joint Total joint replacement Joint prosthesis End-stage joint disease Quality of life Internal medicine RC31-1245 Surgery RD1-811 Michael J. Carter Owen G. Ellis Shreya Tocaciu Michael J. McCullough George Dimitroulis A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
description	Purpose: Alloplastic joint replacement is the mainstay treatment for end-stage temporomandibular joint (TMJ) disease. The aim of this study is to evaluate the 2 year quality of life (QoL) outcomes for patients who have undergone alloplastic TMJ total joint replacement with either custom or stock devices. Methods: This was a retrospective cohort study of patients who had TMJ replacement with either Biomet stock or OMX custom prostheses. All patients were recruited from the patient database of a single surgeon, at a single location. QoL was assessed using a patient completed TMJ Surgery specific QoL (TMJ-S-QoL) questionnaire. Patients answered questions pertaining to pain, diet, speech and aspects related to social and mental health. Results: A 2 year follow up was completed by 26 Biomet and 40 OMX patients. Survey results demonstrated that 84.6% (N = 22) of Biomet stock and 92.5% (N = 37) of OMX custom prosthesis patients derived significant QoL benefits from their surgery. There was no difference in QoL between the two groups (p > 0.4). Conclusion: This study shows that TMJ total joint replacements provide an improved quality of life for patients with end-stage TMJ disease regardless of whether the prosthesis is stock or individually custom made.
format	article
author	Michael J. Carter Owen G. Ellis Shreya Tocaciu Michael J. McCullough George Dimitroulis
author_facet	Michael J. Carter Owen G. Ellis Shreya Tocaciu Michael J. McCullough George Dimitroulis
author_sort	Michael J. Carter
title	A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
title_short	A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
title_full	A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
title_fullStr	A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
title_full_unstemmed	A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements
title_sort	2-year comparison of quality of life outcomes between biomet stock and omx custom temporomandibular joint replacements
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/d73f73585aae423093067f43cdb2cb51
work_keys_str_mv	AT michaeljcarter a2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT owengellis a2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT shreyatocaciu a2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT michaeljmccullough a2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT georgedimitroulis a2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT michaeljcarter 2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT owengellis 2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT shreyatocaciu 2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT michaeljmccullough 2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements AT georgedimitroulis 2yearcomparisonofqualityoflifeoutcomesbetweenbiometstockandomxcustomtemporomandibularjointreplacements
_version_	1718418190260764672

A 2-Year comparison of quality of life outcomes between Biomet stock and OMX custom temporomandibular joint replacements

Ejemplares similares